Section 1: ASP Development & Logistics (Faculty)
In this section, the steward - in - training has just started a new job as the director of a new Antimicrobial Stewardship Program (ASP). This case-based module will help them start
planning the first year in this new leadership role (assembling your multidisciplinary team of experts, conducting a needs assessment of existing tools and resources, meeting regulatory
requirements and benchmarks., etc).
In the later part of the module; they will practice working with NSHN antibiotic use data (AU) to understand how to validate, interpret, analyze, and present this data to relevant stake holders. Either local data from your own institution provided by a local ASP mentor, or a sample data extract can be used for this purpose.
As the faculty or stewardship champion leading this effort, you can decide how the content is distributed and presented to your stewards- in- training.
For Stewards - in - training:
The fellow/trainee can watch the eLearning on their own, followed by a debrief between fellow and faculty.
To present in a classroom or small group setting, you can open the eLearning and let it talk for you, controlling the slides and the pace. You can also disable the audio and narrate the eLearning yourself.
Program Directors, Antimicrobial Stewardship Faculty Champions, and additional Faculty responsible for leading and implementing the Curriculum.
Upon completion of this section, stewards- in- training will be able to:
- Define ASP programmatic goals and expected outcomes
- Formulate a plan to measure and report the efficacy of an ASP
- Identify common process and outcome measures/metrics
- Describe the key steps in establishing an ASP and choosing AS team members
- Demonstrate leadership skills as applicable to AS and leading an ASP
- Consider principles of quality improvement and patient safety when performing AS
- Describe how to implement the core elements of hospital ASPs into practice
- Recognize and be able to perform regulatory and reporting aspects of ASPs (e.g. NHSN AU/AR Reporting)
AS Curriculum Workgroup COI Summary Reviewed April 2017 by Rachel Simmons, MD No conflicts found
|Name||Individual's Role in Activity||Name of Commercial Interest||Nature of Relationship|
|Abbo, Lillian||Workgroup member||Pfizer Brazil||Honoraria|
|Advani, Sonali||Workgroup member||Nabriva Therapeutics||Advisory/Consultant Role|
|Amstrong, Wendy||Workgroup member||None|
|Barsoumian, Alice||Workgroup member||None|
|Beeler, Cole||Workgroup member||None|
|Bystritsky, Rachel||Workgroup member||None|
|Cherabuddi, Kartik||Workgroup member||Gatorade||Start - up Research Fund|
|NIH (Medimmune)||Research Grant|
|Cohen, Seth||Workgroup member||None|
|Hamilton, Keith||Workgroup member||None|
|Ince, Dilek||Workgroup member||Ansun Pharma||Research Grant|
|Justo, Julie Ann||Workgroup member||None|
|Luther, Vera||Workgroup member||None|
|Lynch, John||Workgroup member||Astellas Pharmaceuticals, Juno Therapeutics||Advisory/Consultant Role|
|Nori, Priya||Workgroup member||None|
|Ohl, Christopher||Workgroup member||Paratek, Bayer, Cempra Pharmaceuticals||Advisory/Consultant Role|
|Patel, Payal||Workgroup member||None|
|Pottinger, Paul||Workgroup member||McGraw Hill, Elsevier||Honoraria|
|Schwartz, Brian||Workgroup member||None|
|Spicer, Jennifer||Workgroup member||None|
|Stack, Conor||Workgroup member||None|
|Zhou, Yuan||Workgroup member||None|